Foxf1em1Vvk/Foxf1+
involves: C57BL/6 * DBA/2
|
abnormal gallbladder morphology |
J:296328
|
abnormal lung vasculature morphology |
J:296328
|
abnormal pulmonary alveolus morphology |
J:296328
|
abnormal pulmonary artery morphology |
J:296328
|
abnormal pulmonary vein morphology |
J:296328
|
absent gallbladder |
J:296328
|
decreased angiogenesis |
J:296328
|
decreased lung endothelial cell proliferation |
J:296328
|
fused right lung lobes |
J:296328
|
lung hemorrhage |
J:296328
|
lung inflammation |
J:296328
|
postnatal lethality, incomplete penetrance |
J:296328
|
pulmonary hypoplasia |
J:296328
|
small lung |
J:296328
|
weight loss |
J:296328
|
Foxf1em1Vvk/Foxf1em1Vvk
involves: C57BL/6 * DBA/2
|
embryonic lethality, complete penetrance |
J:296328
|
Foxf1tm1.1Vvk/Foxf1tm1.1Vvk Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
involves: 129 * C57BL/6 * CBA * SJL
|
abnormal vascular branching morphogenesis |
J:240455
|
decreased angiogenesis |
J:240455
|
decreased vascular endothelial cell number |
J:240455
|
Foxf1tm1Pca/Foxf1tm1Pca
either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CD-1) or (involves: 129X1/SvJ * C57BL/6)
|
abnormal allantois morphology |
J:66591
|
abnormal amnion morphology |
J:66591
|
abnormal developmental patterning |
J:66591
|
abnormal embryonic tissue morphology |
J:66591
|
abnormal extraembryonic mesoderm development |
J:66591
|
abnormal extraembryonic tissue morphology |
J:66591
|
abnormal hindgut morphology |
J:66591
|
abnormal lateral plate mesoderm morphology |
J:66591
|
abnormal posterior primitive streak morphology |
J:66591
|
abnormal somite development |
J:66591
|
abnormal visceral yolk sac morphology |
J:66591
|
absent midgut |
J:66591
|
absent vitelline blood vessels |
J:66591
|
delayed somite formation |
J:66591
|
embryonic lethality during organogenesis, complete penetrance |
J:66591
|
failure of chorioallantoic fusion |
J:66591
|
failure of initiation of embryo turning |
J:66591
|
small allantois |
J:66591
|
Foxf1tm1Pca/Foxf1tm1Pca
involves: 129P2/OlaHsd * C57BL/6
|
abnormal visceral yolk sac mesenchyme morphology |
J:128367
|
abnormal visceral yolk sac morphology |
J:128367
|
absent vitelline blood vessels |
J:128367
|
Foxf1tm1Rhc/Foxf1+
involves: 129P3/J * Black Swiss
|
abnormal lung morphology |
J:70364
|
abnormal lung saccule morphology |
J:70364
|
abnormal lung vasculature morphology |
J:70364
|
abnormal surfactant secretion |
J:70364
|
impaired lung alveolus development |
J:70364
|
lung hemorrhage |
J:70364
|
neonatal lethality, incomplete penetrance |
J:70364
|
premature death |
J:70364
|
respiratory distress |
J:70364
|
Foxf1tm1Rhc/Foxf1+
involves: 129P3/J * Black Swiss * CD-1
|
abnormal lung bud morphology |
J:76411
|
abnormal lung development |
J:76411
|
abnormal lung vasculature morphology |
J:76411
|
fused right lung lobes |
J:76411
|
neonatal lethality, complete penetrance |
J:76411
|
Foxf1tm1Rhc/Foxf1tm1Rhc
involves: 129P3/J * Black Swiss
|
lethality throughout fetal growth and development, complete penetrance |
J:70364
|
Foxf1tm2Rhc/Foxf1+ Tg(Myh11-cre,-EGFP)2Mik/0
involves: C57BL/6 * DBA/2
|
abnormal intestinal smooth muscle morphology |
J:203847
|
impaired contractility of intestinal smooth muscle |
J:203847
|
lethality, incomplete penetrance |
J:203847
|
Foxf1tm2Rhc/Foxf1tm2Rhc Tg(Myh11-cre,-EGFP)2Mik/0
involves: C57BL/6 * DBA/2
|
abnormal esophageal smooth muscle morphology |
J:203847
|
dilated esophagus |
J:203847
|
perinatal lethality, complete penetrance |
J:203847
|